At our state-of-the-art drug discovery facility for oligonucleotide synthesis, our team accelerates your early drug discovery. With years of experience in small molecules, we can design molecules, overcoming bioavailability issues, and devising a fast-forward approach for your oligo targets across therapeutic areas such as oncology, inflammation, and anti-bacterial, etc.
Our dedicated oligonucleotide platform helps to encapsulate oligonucleotide molecules for better bioavailability, and CADD trained team helps optimize the designed oligonucleotide along with primary assay iterations. We can Synthesis 10-40-mer oligonucleotide up to 1 gram scale. We can perform all standard modifications, with or without backbone modification, for which phosphoramidites are commercially available. We also have the capabilities of making any customized phosphoramidite in-house
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.